Examples of using Docetaxel in combination in English and their translations into Dutch
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Computer
-
Ecclesiastic
-
Official/political
-
Programming
Docetaxel in combination with trastuzumab.
Patients treated with docetaxel in combination with trastuzumab.
Docetaxel in combination with trastuzumab.
Patients who received docetaxel in combination with capecitabine.
Docetaxel in combination with doxorubicin.
Patients treated with docetaxel in combination with trastuzumab.
Docetaxel in combination with doxorubicin.
Patients who received docetaxel in combination with doxorubicin.
Docetaxel in combination with capecitabine.
When patients are candidates for treatment with docetaxel in combination with trastuzumab, they should undergo baseline cardiac assessment.
Docetaxel in combination with platinum agents in chemotherapy-naïve patients.
Recommended dose modifications for toxicities in patients treated with docetaxel in combination with cisplatin and 5-fluorouracil 5-FU.
Clearance of docetaxel in combination therapy with cisplatin was similar to that observed following monotherapy.
No data are available in patients with hepatic impairment treated by docetaxel in combination in the other indications.
Docetaxel in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with.
No data are available in patients with hepatic impairment treated by docetaxel in combination in the other indications.
Patients who received docetaxel in combination with prednisone or prednisolone clinically important treatment related adverse events are presented.
Recommended dose modifications for toxicities in patients treated with docetaxel in combination with cisplatin and 5-fluorouracil 5-FU.
Docetaxel in combination with prednisone or prednisolone is indicated for the treatment of patients with hormone refractory metastatic prostate cancer.
who received docetaxel in combination with doxorubicin and cyclophosphamide clinically important treatment related adverse events are presented.
Docetaxel in combination with trastuzumab was studied for the treatment of patients with metastatic breast cancer whose tumours over express HER2,
controlled phase III clinical trial support the use of docetaxel in combination with capecitabine for treatment of patients with locally advanced
79 patients in the phase II part) who received docetaxel in combination with cisplatin and 5-fluorouracil clinically important treatment related adverse events are presented.
The safety and efficacy of docetaxel in combination with prednisone or prednisolone in patients with hormone refractory metastatic prostate cancer were evaluated in a randomized multicenter phase III study.
Gastric adenocarcinoma patients(221 patients in the phase III part of the study and 79 patients in the phase II part) who received docetaxel in combination with cisplatin and 5-fluorouracil clinically important treatment related adverse events are presented.
Docetaxel in combination with trastuzumab is indicated for the treatment of patients with metastatic breast cancer whose tumours over express HER2
patients treated with docetaxel in combination with cisplatin and 5-fluorouracil in the gastric cancer study,
And 251 head and neck cancer patients who received docetaxel in combination with cisplatin and 5-fluorouracil clinically important treatment related adverse events are presented.
Heart failure has been observed in patients receiving docetaxel in combination with trastuzumab, particularly following anthracycline(doxorubicin or epirubicin)-containing chemotherapy.